Hoth Therapeutics, Inc. (RKTO) Operating income 2018–2025
Hoth Therapeutics, Inc. (RKTO) annual operating income history from SEC filings — each fiscal year as reported.
-$12.4MFY2025 · since FY2018: -$2.5M → -$12.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.4M | -50.5% |
| FY2024 | -$8.2M | -3.3% |
| FY2023 | -$8.0M | +28.1% |
| FY2022 | -$11.1M | +21.5% |
| FY2021 | -$14.1M | -93.1% |
| FY2020 | -$7.3M | +5.4% |
| FY2019 | -$7.7M | -209.2% |
| FY2018 | -$2.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice